busulfan has been researched along with Thrombopenia in 96 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gemcitabine plus treosulfan (GeT) is under investigation in metastatic uveal melanoma." | 9.11 | Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma. ( Baumgart, J; Bechrakis, NE; Bornfeld, N; Foerster, MH; Keilholz, U; Scheulen, ME; Schmittel, A; Strumberg, D; Thiel, E, 2005) |
| "We previously demonstrated that Busulfan-Thiotepa (Bu-Thio) and ASCT effectively treated patients with locally relapsed medulloblastoma after surgery and conventional chemotherapy." | 9.11 | High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy. ( Benhamou, E; Couanet, D; Fillipini, B; Grill, J; Habrand, JL; Hartmann, O; Kalifa, C; Valteau-Couanet, D, 2005) |
| " In the in vivo study tissue distribution of nanocurcumin was determined and two treatment schedules were used to evaluate the capability of nanocurcumin to prevent the occurrence of Busulfan-induced thrombocytopenia in the mouse model." | 7.96 | Nanocurcumin as a novel stimulator of megakaryopoiesis that ameliorates chemotherapy-induced thrombocytopenia in mice. ( Gholampour, MA; Mortazavi Farsani, SS; Najafi, F; Sadeghizadeh, M; Safari, Z, 2020) |
| " We developed a model of nonimmune thrombocytopenia in rabbits by the subcutaneous administration of busulfan." | 7.69 | The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. ( Kuter, DJ; Rosenberg, RD, 1995) |
| "Three patients with Wiskott-Aldrich syndrome received transplants of marrow from their HLA-A, B, C, D identical siblings after myeloablation with busulfan, 2 mg/kg/day x 4 days, followed by immunosuppression with cyclophosphamide, 50 mg/kg/day x 4." | 7.66 | Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with busulfan and cyclophosphamide. ( Blaese, RM; Chaganti, RS; Good, RA; Hilgartner, MH; Kapoor, N; Kirkpatrick, D; O'Reilly, RJ; Oleske, J, 1981) |
| "The effect of hydroxyurea in 35 patients with chronic granulocytic leukemia (CGL), who either had entered an accelerated phase of the disease or had experienced excessive myelosuppression following alkylating agents, was studied." | 7.65 | Hydroxyurea in the management of the hematologic complications of chronic granulocytic leukemia. ( Cannellos, GP; Schwartz, JH, 1975) |
| "Uveal melanoma is relatively uncommon accounting for fewer than 5% of all melanoma cases." | 6.72 | A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma. ( Butt, M; Eswar, CV; Gillis, P; Marshall, E; O'Neill, PA, 2006) |
| "Animal models of thrombocytopenia are indispensable for evaluating the in vivo efficacy of hemostatic agents, cryopreserved platelets, and artificial platelets, but no large animal models are available." | 5.43 | A swine model of acute thrombocytopenia with prolonged bleeding time produced by busulfan. ( Abe, T; Hanazono, Y; Hishikawa, S; Kono, S; Kunita, S; Ohnuki, T, 2016) |
| " For the purpose of efficient function as platelet substitute, H12-(ADP)-liposomes should potentially have both acceptable pharmacokinetic and biodegradable properties under conditions of an adaptation disease including thrombocytopenia induced by anticancer drugs." | 5.39 | Pharmacokinetic study of adenosine diphosphate-encapsulated liposomes coated with fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute in an anticancer drug-induced thrombocytopenia rat model. ( Doi, M; Fujiyama, A; Handa, M; Ikeda, Y; Maruyama, T; Otagiri, M; Taguchi, K; Takeoka, S; Ujihira, H; Watanabe, H, 2013) |
| "Fat embolism was induced in rabbits by giving an intravenous injection of radioactively labelled homologous retroperitoneal fat." | 5.26 | Induced fat embolism in rabbits: effects of defibrinogenation and thrombocytopenia. ( Lahnborg, G; Nylén, S; Sylvén, C, 1976) |
| "Gemcitabine plus treosulfan (GeT) is under investigation in metastatic uveal melanoma." | 5.11 | Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma. ( Baumgart, J; Bechrakis, NE; Bornfeld, N; Foerster, MH; Keilholz, U; Scheulen, ME; Schmittel, A; Strumberg, D; Thiel, E, 2005) |
| "We previously demonstrated that Busulfan-Thiotepa (Bu-Thio) and ASCT effectively treated patients with locally relapsed medulloblastoma after surgery and conventional chemotherapy." | 5.11 | High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy. ( Benhamou, E; Couanet, D; Fillipini, B; Grill, J; Habrand, JL; Hartmann, O; Kalifa, C; Valteau-Couanet, D, 2005) |
| "Autologous stem cell transplantation after high-dose melphalan for the treatment with multiple myeloma has resulted in prolonged progression-free survival and overall survival in patients under 65 years." | 5.09 | The role of autologous transplantation in patients with multiple myeloma aged 65 years and over. ( Bhagwati, N; Horton, C; Kulkarni, S; Mainwaring, P; Mehta, J; Pandha, H; Powles, R; Singhal, S; Sirohi, B; Treleaven, J, 2000) |
| " In the in vivo study tissue distribution of nanocurcumin was determined and two treatment schedules were used to evaluate the capability of nanocurcumin to prevent the occurrence of Busulfan-induced thrombocytopenia in the mouse model." | 3.96 | Nanocurcumin as a novel stimulator of megakaryopoiesis that ameliorates chemotherapy-induced thrombocytopenia in mice. ( Gholampour, MA; Mortazavi Farsani, SS; Najafi, F; Sadeghizadeh, M; Safari, Z, 2020) |
| "Autologous stem cell transplantation (ASCT) with high-dose thiotepa and busulfan is a treatment option for patients with central nervous system (CNS) lymphoma." | 3.96 | Secondary failure of platelet recovery in patients treated with high-dose thiotepa and busulfan followed by autologous stem cell transplantation. ( Aiba, A; Hishizawa, M; Kitano, T; Kondo, T; Nishikori, M; Shimazu, Y; Shindo, T; Takaori-Kondo, A; Wada, F; Watanabe, M, 2020) |
| "Guinea pigs were chronically treated with busulfan to induce thrombocytopenia." | 3.81 | Bradykinin and capsaicin induced airways obstruction in the guinea pig are platelet dependent. ( Keir, SD; Page, CP; Spina, D, 2015) |
| " Thrombocytopenia was induced in rabbits by busulfan treatment and the effect on catheter injury development examined after 15 days." | 3.72 | Role of platelet activation in catheter-induced vascular wall injury. ( Bertipaglia, B; Chiavegato, A; Filipetto, C; Gamba, P; Gasparotto, L; Sartore, S; Taiani, J; Zolpi, E, 2004) |
| " Rats treated with busulfan to induce thrombocytopenia exhibited a 90% decrease in circulating platelets." | 3.69 | Involvement of nitric oxide and cyclooxygenase products in photoactivation-induced microvascular occlusion. ( Lentsch, AB; Lindberg, RA; Miller, FN; Slaaf, DW, 1994) |
| " We developed a model of nonimmune thrombocytopenia in rabbits by the subcutaneous administration of busulfan." | 3.69 | The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. ( Kuter, DJ; Rosenberg, RD, 1995) |
| "Three patients with Wiskott-Aldrich syndrome received transplants of marrow from their HLA-A, B, C, D identical siblings after myeloablation with busulfan, 2 mg/kg/day x 4 days, followed by immunosuppression with cyclophosphamide, 50 mg/kg/day x 4." | 3.66 | Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with busulfan and cyclophosphamide. ( Blaese, RM; Chaganti, RS; Good, RA; Hilgartner, MH; Kapoor, N; Kirkpatrick, D; O'Reilly, RJ; Oleske, J, 1981) |
| " After 15 months of control with splenic irradiation, rising blood counts necessitated busulfan therapy, producing severe thrombocytopenia which persisted for nearly three years." | 3.66 | Chronic myelogenous leukemia: a 22-year survival. ( Flexner, JM; Stein, RS, 1980) |
| " Inhibition of platelet aggregation by a pyrimido-pyrimidine compound (SH 869) or thrombocytopenia induced by Busulfan or antiplatelet antiserum did not significantly protect the animals from the cardiovascular effects of ADP." | 3.66 | Contribution of platelets to the cardiovascular effects of ADP in the rat. ( Bonaccorsi, A; Castelli, MG; De Gaetano, G; Dejana, E, 1978) |
| " Granulocytopenia and thrombocytopenia induced by feeding the cytoxic drug busulfan prevented the activation of intravascular coagulation and the occurrence of renal glomerular microclots after two injections of endotoxin." | 3.65 | The effect of leukocyte and platelet transfusion on the activation of intravascular coagulation by endotoxin in granulocytopenic and thrombocytopenic rabbits. ( Bohn, E; Müller-Berghaus, G, 1976) |
| "The effect of hydroxyurea in 35 patients with chronic granulocytic leukemia (CGL), who either had entered an accelerated phase of the disease or had experienced excessive myelosuppression following alkylating agents, was studied." | 3.65 | Hydroxyurea in the management of the hematologic complications of chronic granulocytic leukemia. ( Cannellos, GP; Schwartz, JH, 1975) |
| "Uveal melanoma is relatively uncommon accounting for fewer than 5% of all melanoma cases." | 2.72 | A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma. ( Butt, M; Eswar, CV; Gillis, P; Marshall, E; O'Neill, PA, 2006) |
| "Thrombocytopoiesis of 21 multiple myeloma patients undergoing single or double transplant regimen was characterized by measuring the level of reticulated platelets and plasma glycocalicin." | 2.69 | Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets. ( Castellani, S; Catani, L; Lemoli, RM; Luatti, S; Rizzi, S; Tura, S; Valdrè, L; Vianelli, N, 1999) |
| "It is concluded that there is no evidence that either of the two cytotoxic drugs in the dosage prescribed improved survival for the two-year period of observation, though a final evaluation of the adjuvant chemotherapy as studied in this investigation will have to await the results at five years." | 2.64 | Study of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus. Report by a Medical Research Council Working Party. ( , 1971) |
| "Animal models of thrombocytopenia are indispensable for evaluating the in vivo efficacy of hemostatic agents, cryopreserved platelets, and artificial platelets, but no large animal models are available." | 1.43 | A swine model of acute thrombocytopenia with prolonged bleeding time produced by busulfan. ( Abe, T; Hanazono, Y; Hishikawa, S; Kono, S; Kunita, S; Ohnuki, T, 2016) |
| "Carpaine was isolated from the alkaloid fraction and exhibited potent activity in sustaining platelet counts upto 555." | 1.43 | Antithrombocytopenic activity of carpaine and alkaloidal extract of Carica papaya Linn. leaves in busulfan induced thrombocytopenic Wistar rats. ( Dash, RP; Jivrajani, M; Nivsarkar, M; Trivedi, B; Zunjar, V, 2016) |
| " For the purpose of efficient function as platelet substitute, H12-(ADP)-liposomes should potentially have both acceptable pharmacokinetic and biodegradable properties under conditions of an adaptation disease including thrombocytopenia induced by anticancer drugs." | 1.39 | Pharmacokinetic study of adenosine diphosphate-encapsulated liposomes coated with fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute in an anticancer drug-induced thrombocytopenia rat model. ( Doi, M; Fujiyama, A; Handa, M; Ikeda, Y; Maruyama, T; Otagiri, M; Taguchi, K; Takeoka, S; Ujihira, H; Watanabe, H, 2013) |
| "Remarkably, hyperalgesia evoked by Bjv or carrageenan was completely blocked in animals treated with ARPI or busulfan, or pre-treated with aspirin or clopidogrel." | 1.37 | Involvement of circulating platelets on the hyperalgesic response evoked by carrageenan and Bothrops jararaca snake venom. ( Cirillo, MC; Giorgi, R; Gonçalves, LR; Nogueira, TO; Sano-Martins, IS; Santoro, ML; Senise, LV; Yamashita, KM, 2011) |
| "Thrombocytopenia was induced in rabbits by the intraperitoneal injection of busulphan dissolved in polyethylene glycol (PEG) at a dose of 60 mg/kg." | 1.27 | A platelet release defect induced by aspirin or penicillin G does not increase gastrointestinal blood loss in thrombocytopenic rabbits. ( Giles, AR; Greenwood, P; Tinlin, S, 1984) |
| "Fat embolism was induced in rabbits by giving an intravenous injection of radioactively labelled homologous retroperitoneal fat." | 1.26 | Induced fat embolism in rabbits: effects of defibrinogenation and thrombocytopenia. ( Lahnborg, G; Nylén, S; Sylvén, C, 1976) |
| "Thrombocytopenia was induced by feeding rabbits busulphan, and soluble fibrin was produced by infusing ancrod." | 1.25 | The role of blood platelets in the precipitation of soluble fibrin by endotoxin. ( Eckhardt, T; Müller-Berghaus, G, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 57 (59.38) | 18.7374 |
| 1990's | 15 (15.63) | 18.2507 |
| 2000's | 12 (12.50) | 29.6817 |
| 2010's | 10 (10.42) | 24.3611 |
| 2020's | 2 (2.08) | 2.80 |
| Authors | Studies |
|---|---|
| Mortazavi Farsani, SS | 1 |
| Sadeghizadeh, M | 1 |
| Gholampour, MA | 1 |
| Safari, Z | 1 |
| Najafi, F | 1 |
| Wada, F | 1 |
| Nishikori, M | 1 |
| Hishizawa, M | 1 |
| Watanabe, M | 1 |
| Aiba, A | 1 |
| Kitano, T | 1 |
| Shimazu, Y | 1 |
| Shindo, T | 1 |
| Kondo, T | 1 |
| Takaori-Kondo, A | 1 |
| Burdette, AJ | 1 |
| Andrew Pratt, G | 1 |
| Campagna, MV | 1 |
| Sheppard, FR | 1 |
| Taguchi, K | 1 |
| Ujihira, H | 1 |
| Watanabe, H | 1 |
| Fujiyama, A | 1 |
| Doi, M | 1 |
| Takeoka, S | 2 |
| Ikeda, Y | 2 |
| Handa, M | 2 |
| Otagiri, M | 1 |
| Maruyama, T | 1 |
| Jy, W | 1 |
| Johansen, ME | 1 |
| Bidot, C | 1 |
| Horstman, LL | 1 |
| Ahn, YS | 1 |
| Kanaji, S | 1 |
| Fahs, SA | 1 |
| Ware, J | 1 |
| Montgomery, RR | 1 |
| Shi, Q | 1 |
| Keir, SD | 1 |
| Spina, D | 1 |
| Page, CP | 2 |
| Zunjar, V | 1 |
| Dash, RP | 1 |
| Jivrajani, M | 1 |
| Trivedi, B | 1 |
| Nivsarkar, M | 1 |
| Abe, T | 1 |
| Kono, S | 1 |
| Ohnuki, T | 1 |
| Hishikawa, S | 1 |
| Kunita, S | 1 |
| Hanazono, Y | 1 |
| Kang, EM | 1 |
| Choi, U | 1 |
| Theobald, N | 1 |
| Linton, G | 1 |
| Long Priel, DA | 1 |
| Kuhns, D | 1 |
| Malech, HL | 1 |
| Kornerup, KN | 1 |
| Salmon, GP | 1 |
| Pitchford, SC | 1 |
| Liu, WL | 1 |
| Yamashita, KM | 1 |
| Nogueira, TO | 1 |
| Senise, LV | 1 |
| Cirillo, MC | 1 |
| Gonçalves, LR | 1 |
| Sano-Martins, IS | 1 |
| Giorgi, R | 1 |
| Santoro, ML | 1 |
| CHAPTAL, J | 1 |
| JEAN, R | 1 |
| IZARN, P | 1 |
| BONNET, H | 1 |
| NAVARRO, M | 1 |
| EMBERGER, JM | 1 |
| HARDISTY, RM | 1 |
| SPEED, DE | 1 |
| TILL, M | 1 |
| CLIFFORD, P | 1 |
| CLIFT, RA | 1 |
| KHAN, AG | 1 |
| TIMMIS, GM | 1 |
| RYDER, RJ | 1 |
| Zolpi, E | 1 |
| Filipetto, C | 1 |
| Bertipaglia, B | 1 |
| Taiani, J | 1 |
| Gasparotto, L | 1 |
| Chiavegato, A | 1 |
| Gamba, P | 1 |
| Sartore, S | 1 |
| Schmittel, A | 1 |
| Scheulen, ME | 1 |
| Bechrakis, NE | 1 |
| Strumberg, D | 1 |
| Baumgart, J | 1 |
| Bornfeld, N | 1 |
| Foerster, MH | 1 |
| Thiel, E | 1 |
| Keilholz, U | 1 |
| Okamura, Y | 1 |
| Teramura, Y | 1 |
| Maruyama, H | 1 |
| Tsuchida, E | 1 |
| Valteau-Couanet, D | 2 |
| Faucher, C | 1 |
| Aupérin, A | 1 |
| Michon, J | 1 |
| Milpied, N | 1 |
| Boiron, JM | 1 |
| Bourhis, JH | 1 |
| Gisselbrecht, C | 1 |
| Vernant, JP | 1 |
| Pinna, A | 1 |
| Bendahmane, B | 1 |
| Delabarre, F | 1 |
| Benhamou, E | 2 |
| Fillipini, B | 1 |
| Grill, J | 1 |
| Kalifa, C | 1 |
| Couanet, D | 1 |
| Habrand, JL | 1 |
| Hartmann, O | 1 |
| Lesurtel, M | 1 |
| Graf, R | 1 |
| Aleil, B | 1 |
| Walther, DJ | 1 |
| Tian, Y | 1 |
| Jochum, W | 1 |
| Gachet, C | 1 |
| Bader, M | 1 |
| Clavien, PA | 1 |
| Kiefer, T | 1 |
| Krüger, WH | 1 |
| Schüler, F | 1 |
| Lotze, C | 1 |
| Hirt, C | 1 |
| Dölken, G | 1 |
| O'Neill, PA | 1 |
| Butt, M | 1 |
| Eswar, CV | 1 |
| Gillis, P | 1 |
| Marshall, E | 1 |
| Tamagawa-Mineoka, R | 1 |
| Katoh, N | 1 |
| Ueda, E | 1 |
| Takenaka, H | 1 |
| Kita, M | 1 |
| Kishimoto, S | 1 |
| Busuttil, DP | 1 |
| Giles, AR | 1 |
| Greenwood, P | 1 |
| Tinlin, S | 1 |
| Stein, RS | 1 |
| Flexner, JM | 1 |
| Kapoor, N | 1 |
| Kirkpatrick, D | 1 |
| Blaese, RM | 1 |
| Oleske, J | 1 |
| Hilgartner, MH | 1 |
| Chaganti, RS | 1 |
| Good, RA | 1 |
| O'Reilly, RJ | 1 |
| Lindberg, RA | 1 |
| Slaaf, DW | 1 |
| Lentsch, AB | 1 |
| Miller, FN | 1 |
| Kuter, DJ | 5 |
| Rosenberg, RD | 3 |
| Beeler, DL | 1 |
| Shepherd, PC | 1 |
| Richards, S | 1 |
| Allan, NC | 1 |
| Srivastava, A | 1 |
| Bradstock, KF | 1 |
| Szer, J | 1 |
| de Bortoli, L | 1 |
| Gottlieb, DJ | 1 |
| Ozsahin, H | 1 |
| Le Deist, F | 1 |
| Benkerrou, M | 1 |
| Cavazzana-Calvo, M | 1 |
| Gomez, L | 1 |
| Griscelli, C | 1 |
| Blanche, S | 1 |
| Fischer, A | 1 |
| Sirois, MG | 1 |
| Simons, M | 1 |
| Edelman, ER | 1 |
| Hara, J | 1 |
| Osugi, Y | 1 |
| Ohta, H | 1 |
| Matsuda, Y | 1 |
| Nakanishi, K | 1 |
| Takai, K | 1 |
| Fujisaki, H | 1 |
| Tokimasa, S | 1 |
| Fukuzawa, M | 1 |
| Okada, A | 1 |
| Okada, S | 1 |
| Yang, C | 1 |
| Li, YC | 1 |
| Catani, L | 1 |
| Vianelli, N | 1 |
| Luatti, S | 1 |
| Rizzi, S | 1 |
| Castellani, S | 1 |
| Valdrè, L | 1 |
| Lemoli, RM | 1 |
| Tura, S | 1 |
| Sirohi, B | 1 |
| Powles, R | 1 |
| Treleaven, J | 1 |
| Mainwaring, P | 1 |
| Kulkarni, S | 1 |
| Pandha, H | 1 |
| Bhagwati, N | 1 |
| Horton, C | 1 |
| Singhal, S | 1 |
| Mehta, J | 1 |
| Berrebi, A | 1 |
| Shvidel, L | 1 |
| Shtalrid, M | 1 |
| Klepfish, A | 1 |
| Douglas, ID | 1 |
| Wiltshaw, E | 1 |
| Bell, R | 1 |
| Sullivan, JR | 1 |
| Hurley, TH | 1 |
| D'Apice, AJ | 1 |
| Kincaid-Smith, P | 1 |
| Schilling, RF | 1 |
| Crowley, JJ | 1 |
| Markwardt, F | 1 |
| Nowak, G | 1 |
| Glusa, E | 1 |
| Hoffman, A | 1 |
| Dejana, E | 1 |
| Castelli, MG | 1 |
| De Gaetano, G | 1 |
| Bonaccorsi, A | 1 |
| Stott, H | 2 |
| Stephens, RJ | 2 |
| Fox, W | 2 |
| Roy, DC | 1 |
| Hussain, S | 1 |
| Bohn, E | 2 |
| Müller-Berghaus, G | 3 |
| Rapaport, SI | 1 |
| Zivelin, A | 1 |
| Lahnborg, G | 1 |
| Nylén, S | 1 |
| Sylvén, C | 1 |
| Schwartz, JH | 1 |
| Cannellos, GP | 1 |
| Klein, UE | 1 |
| Schwarze, EW | 1 |
| Schwalbe, P | 1 |
| Tolksdorf, ME | 1 |
| Eckhardt, T | 1 |
| Kobayashi, I | 1 |
| Didisheim, P | 1 |
| Höbel, W | 1 |
| Nese, M | 1 |
| Oyekan, AO | 1 |
| Onabanjo, AO | 1 |
| Vermylen, C | 1 |
| Cornu, G | 1 |
| Philippe, M | 1 |
| Ninane, J | 1 |
| Borja, A | 1 |
| Latinne, D | 1 |
| Ferrant, A | 1 |
| Michaux, JL | 1 |
| Sokal, G | 1 |
| Fiedler, W | 1 |
| Goetz, G | 1 |
| Weh, HJ | 1 |
| Hossfeld, DK | 1 |
| Silver, RT | 1 |
| Mick, R | 1 |
| Cooper, R | 1 |
| Ellison, RR | 1 |
| Levy, R | 1 |
| Brunner, K | 1 |
| Schwartz, JM | 1 |
| Holland, JF | 1 |
| Girling, DJ | 1 |
| Chia, YC | 1 |
| Cattell, V | 1 |
| Möller, H | 1 |
| Waldenström, J | 1 |
| Ganda, OP | 1 |
| Mangalik, A | 1 |
| Canellos, GP | 1 |
| Nordland, J | 1 |
| Carbone, PP | 1 |
| Harker, LA | 1 |
| Skjorten, F | 1 |
| Evensen, SA | 6 |
| Dyk, T | 1 |
| Piotrowski, M | 1 |
| Kostecka, W | 1 |
| Bergqvist, D | 1 |
| Arfors, KE | 1 |
| Perugini, S | 1 |
| Ascari, E | 1 |
| Fontana, G | 1 |
| Schmidt, M | 1 |
| Havemann, K | 1 |
| Ward, HP | 1 |
| Block, MH | 1 |
| Alberto, P | 1 |
| Maurice, PA | 1 |
| Dube, B | 1 |
| Bajpai, HS | 1 |
| Chawla, SC | 1 |
| Gupta, YN | 1 |
| Elgjo, RF | 1 |
| Jörgensen, L | 1 |
| Husby, G | 1 |
| Ernst, P | 1 |
| Boye Nielsen, J | 1 |
| Killman, SE | 1 |
| Pawelski, S | 1 |
| Topolska, P | 1 |
| Rechowicz, K | 1 |
| Olesen, J | 1 |
| Videbaek, A | 1 |
| Albrecht, M | 1 |
| Tackmann, W | 1 |
| Pribilla, W | 1 |
| Gralnick, HR | 1 |
| Harbor, J | 1 |
| Vogel, C | 1 |
| Winkelman, J | 1 |
| Fisher, H | 1 |
| Melnyk, J | 1 |
| Grubb, J | 1 |
| Lucas, J | 1 |
| Robertson, JH | 1 |
| Crozier, EH | 1 |
| Woodend, BE | 1 |
| Jeremic, M | 4 |
| Benkö, S | 1 |
| Benkö, K | 1 |
| Török, L | 1 |
| Prankerd, TA | 1 |
| Penttilä, O | 1 |
| Ikkala, E | 1 |
| Hjort, PF | 2 |
| Vallée, G | 1 |
| Boivin, P | 1 |
| Dormont, J | 1 |
| Soulier, JP | 1 |
| Hooey, MA | 1 |
| Crookston, JH | 1 |
| Squires, AH | 1 |
| Kyle, RA | 1 |
| Pease, GL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Autologous Transplantation of Genetically Modified Cells for the Treatment of X-Linked Chronic Granulomatous Disease[NCT00394316] | Early Phase 1 | 3 participants (Actual) | Interventional | 2006-10-30 | Terminated | ||
| Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency[NCT01306019] | Phase 1/Phase 2 | 19 participants (Actual) | Interventional | 2012-09-25 | Suspended (stopped due to Clones representing 10% or more of the subject patients myeloid lineage have been detected, no evidence of malignancy found.) | ||
| A Multicentric, Exploratory, Non-randomised, Non-controlled, Prospective, Open-label Phase II Study Evaluating Safety and Efficacy of IBU, G-CSF and Plerixafor as Stem Cell Mobilization Regimen in Patients Affected by X-CGD[NCT03055247] | Phase 2 | 3 participants (Anticipated) | Interventional | 2015-11-06 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for busulfan and Thrombopenia
| Article | Year |
|---|---|
The physiology of platelet production.
Topics: Animals; Blood Cell Count; Blood Platelets; Bone Marrow Cells; Busulfan; Cytokines; Humans; Megakary | 1996 |
Disorders of hemostasis and thrombosis in the aged.
Topics: Adolescent; Adult; Aged; Aortic Aneurysm; Blood Coagulation Disorders; Blood Coagulation Factors; Bl | 1976 |
Control of platelet production.
Topics: Androgens; Animals; Blood Platelets; Busulfan; Cell Nucleus; Cytoplasm; Diploidy; Erythropoietin; Es | 1974 |
[Current therapeutic possibilities in idiopathic myelofibrosis. Observations on 47 cases].
Topics: Adrenal Cortex Hormones; Adult; Androgens; Anemia; Busulfan; Drug Synergism; Female; Humans; Leukocy | 1968 |
The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome.
Topics: Adrenal Cortex Hormones; Alkaline Phosphatase; Androgens; Anemia; Animals; Blood Cell Count; Blood C | 1971 |
13 trials available for busulfan and Thrombopenia
| Article | Year |
|---|---|
Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.
Topics: Adult; Aspergillosis; Busulfan; Chromosomes, Human, X; Combined Modality Therapy; Genetic Therapy; G | 2010 |
Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.
Topics: Adult; Aspergillosis; Busulfan; Chromosomes, Human, X; Combined Modality Therapy; Genetic Therapy; G | 2010 |
Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.
Topics: Adult; Aspergillosis; Busulfan; Chromosomes, Human, X; Combined Modality Therapy; Genetic Therapy; G | 2010 |
Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.
Topics: Adult; Aspergillosis; Busulfan; Chromosomes, Human, X; Combined Modality Therapy; Genetic Therapy; G | 2010 |
Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.
Topics: Adult; Aspergillosis; Busulfan; Chromosomes, Human, X; Combined Modality Therapy; Genetic Therapy; G | 2010 |
Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.
Topics: Adult; Aspergillosis; Busulfan; Chromosomes, Human, X; Combined Modality Therapy; Genetic Therapy; G | 2010 |
Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.
Topics: Adult; Aspergillosis; Busulfan; Chromosomes, Human, X; Combined Modality Therapy; Genetic Therapy; G | 2010 |
Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.
Topics: Adult; Aspergillosis; Busulfan; Chromosomes, Human, X; Combined Modality Therapy; Genetic Therapy; G | 2010 |
Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.
Topics: Adult; Aspergillosis; Busulfan; Chromosomes, Human, X; Combined Modality Therapy; Genetic Therapy; G | 2010 |
Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma.
Topics: Adult; Aged; Anemia; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplas | 2005 |
Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trial.
Topics: Adolescent; Adult; Aged; Blood Transfusion; Busulfan; Child; Child, Preschool; Cost-Benefit Analysis | 2005 |
High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Combi | 2005 |
A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Dacarbazine; Female; Humans; | 2006 |
Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Behavior Therapy; Biomarkers; Blood | 1999 |
The role of autologous transplantation in patients with multiple myeloma aged 65 years and over.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Chem | 2000 |
5-year follow-up of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus.
Topics: Bronchial Neoplasms; Busulfan; Clinical Trials as Topic; Cyclophosphamide; Female; Follow-Up Studies | 1976 |
[Therapy of chronic myeloid leukemia with interferon, alone or combined. Preliminary experience].
Topics: Adolescent; Adult; Aged; Busulfan; Combined Modality Therapy; Female; Humans; Hydroxyurea; Immunolog | 1991 |
A comparative study of dibromomannitol and busulfan in the treatment of chronic myeloid leukemia. A study of cancer and leukemia group B.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Busulfan; Child; Child, Preschool; Clinical Trials as To | 1987 |
Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma.
Topics: Aged; Busulfan; Carcinoma, Bronchogenic; Clinical Trials as Topic; Combined Modality Therapy; Cyclop | 1985 |
Psoriasis treated with busulfan.
Topics: Adult; Busulfan; Clinical Trials as Topic; Female; Humans; Leukopenia; Male; Middle Aged; Placebos; | 1970 |
Study of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus. Report by a Medical Research Council Working Party.
Topics: Adult; Aged; Anemia, Hemolytic; Bronchial Neoplasms; Busulfan; Clinical Trials as Topic; Cyclophosph | 1971 |
78 other studies available for busulfan and Thrombopenia
| Article | Year |
|---|---|
Nanocurcumin as a novel stimulator of megakaryopoiesis that ameliorates chemotherapy-induced thrombocytopenia in mice.
Topics: Animals; Antineoplastic Agents, Alkylating; Blood Platelets; Busulfan; Curcumin; Female; Hematopoiet | 2020 |
Secondary failure of platelet recovery in patients treated with high-dose thiotepa and busulfan followed by autologous stem cell transplantation.
Topics: Adult; Aged; Busulfan; Central Nervous System Neoplasms; Female; Hematopoietic Stem Cell Transplanta | 2020 |
Evaluation of a new generation platelet-derived hemostatic agent in a rabbit thrombocytopenic model.
Topics: Animals; Blood Platelets; Busulfan; Disease Models, Animal; Hemostatics; Humans; Rabbits; Thrombocyt | 2017 |
Pharmacokinetic study of adenosine diphosphate-encapsulated liposomes coated with fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute in an anticancer drug-induced thrombocytopenia rat model.
Topics: Adenosine Diphosphate; Animals; Antineoplastic Agents; Blood Platelets; Blood Substitutes; Busulfan; | 2013 |
Red cell-derived microparticles (RMP) as haemostatic agent.
Topics: Adenosine Diphosphate; Animals; Bleeding Time; Blood Coagulation Disorders; Busulfan; Cell Separatio | 2013 |
Non-myeloablative conditioning with busulfan before hematopoietic stem cell transplantation leads to phenotypic correction of murine Bernard-Soulier syndrome.
Topics: Animals; Bernard-Soulier Syndrome; Bleeding Time; Busulfan; Disease Models, Animal; Gene Transfer Te | 2014 |
Bradykinin and capsaicin induced airways obstruction in the guinea pig are platelet dependent.
Topics: Airway Obstruction; Animals; Blood Platelets; Bombesin; Bradykinin; Bronchoconstriction; Busulfan; C | 2015 |
Antithrombocytopenic activity of carpaine and alkaloidal extract of Carica papaya Linn. leaves in busulfan induced thrombocytopenic Wistar rats.
Topics: Alkaloids; Animals; Blood Platelets; Busulfan; Carica; Chromatography, Liquid; Fibrinolytic Agents; | 2016 |
A swine model of acute thrombocytopenia with prolonged bleeding time produced by busulfan.
Topics: Acute Disease; Animals; Antineoplastic Agents, Alkylating; Bleeding Time; Busulfan; Disease Models, | 2016 |
Circulating platelet-neutrophil complexes are important for subsequent neutrophil activation and migration.
Topics: Adult; Animals; Blood Platelets; Bronchoalveolar Lavage Fluid; Busulfan; CD18 Antigens; Cells, Cultu | 2010 |
Involvement of circulating platelets on the hyperalgesic response evoked by carrageenan and Bothrops jararaca snake venom.
Topics: Animals; Aspirin; Blood Platelets; Bothrops; Busulfan; Carrageenan; Clopidogrel; Crotalid Venoms; Cy | 2011 |
[CHRONIC MYELOID LEUKOSIS IN CHILDREN: 4 CASES].
Topics: Blood Platelet Disorders; Busulfan; Child; Humans; Leukemia; Leukemia, Myeloid; Leukocytosis; Lymph | 1963 |
GRANULOCYTIC LEUKAEMIA IN CHILDHOOD.
Topics: Adrenal Cortex Hormones; Alkaline Phosphatase; Blood Cell Count; Bone Marrow Examination; Busulfan; | 1964 |
DIMETHYL MYLERAN THERAPY COMBINED WITH ABDOMINAL AORTIC OCCLUSION.
Topics: Adolescent; Alopecia; Aorta; Aorta, Abdominal; Busulfan; Chemotherapy, Cancer, Regional Perfusion; D | 1964 |
HAEMORRHAGIC THROMBOCYTHAEMIA.
Topics: Blood Coagulation Tests; Blood Platelet Disorders; Blood Platelets; Busulfan; Drug Therapy; Humans; | 1965 |
Role of platelet activation in catheter-induced vascular wall injury.
Topics: Animals; Blotting, Western; Busulfan; Catheterization, Peripheral; Cells, Cultured; Endothelium, Vas | 2004 |
Hemostatic effects of fibrinogen gamma-chain dodecapeptide-conjugated polymerized albumin particles in vitro and in vivo.
Topics: Albumins; Animals; Bleeding Time; Blood Platelets; Blood Substitutes; Busulfan; Carbocyanines; Cell | 2005 |
Platelet-derived serotonin mediates liver regeneration.
Topics: 5-Hydroxytryptophan; Amphetamines; Animals; Blood Platelets; Busulfan; Cell Proliferation; Clopidogr | 2006 |
The modification of high-dose therapy shortens the duration of neutropaenia by delay of leucocyte nadir.
Topics: Adolescent; Adult; Aged; Busulfan; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Infec | 2006 |
The role of platelets in leukocyte recruitment in chronic contact hypersensitivity induced by repeated elicitation.
Topics: Animals; Antibodies; Blood Platelets; Busulfan; Dermatitis, Contact; Ear; Gene Expression Profiling; | 2007 |
Prolonged imatinib-induced myelosuppression in chronic myeloid leukaemia with an unusually long survival.
Topics: Adult; Antineoplastic Agents; Benzamides; Blast Crisis; Busulfan; Fatal Outcome; Humans; Imatinib Me | 2008 |
A platelet release defect induced by aspirin or penicillin G does not increase gastrointestinal blood loss in thrombocytopenic rabbits.
Topics: Animals; Aspirin; Blood Platelet Disorders; Busulfan; Gastrointestinal Hemorrhage; Male; Penicillin | 1984 |
Chronic myelogenous leukemia: a 22-year survival.
Topics: Adult; Busulfan; Female; Humans; Leukemia, Myeloid; Prognosis; Thrombocytopenia; Time Factors | 1980 |
Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with busulfan and cyclophosphamide.
Topics: Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Chromosomes, Human, 13-15; Cyclophos | 1981 |
Involvement of nitric oxide and cyclooxygenase products in photoactivation-induced microvascular occlusion.
Topics: Amino Acid Oxidoreductases; Animals; Arterioles; Blood Platelets; Busulfan; Cyclooxygenase Inhibitor | 1994 |
The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit.
Topics: Animals; Blood Platelets; Bone Marrow Cells; Busulfan; Hematopoiesis; Leukopenia; Male; Megakaryocyt | 1995 |
The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production.
Topics: Amino Acid Sequence; Animals; Blood Platelets; Busulfan; Glycoproteins; Growth Substances; Hematopoi | 1994 |
Severe cytopenias associated with the sequential use of busulphan and interferon-alpha in chronic myeloid leukaemia.
Topics: Adult; Aged; Bone Marrow Diseases; Busulfan; Combined Modality Therapy; Female; Humans; Hydroxyurea; | 1994 |
Busulphan and melphalan prior to autologous bone marrow transplantation.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone | 1993 |
Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center.
Topics: Adolescent; Antibodies, Monoclonal; Autoimmune Diseases; B-Lymphocytes; Bone Marrow Transplantation; | 1996 |
Rat arterial wall retains myointimal hyperplastic potential long after arterial injury.
Topics: Animals; Busulfan; Carotid Artery Injuries; Carotid Artery, Common; Carotid Stenosis; Hyperplasia; M | 1997 |
Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors.
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; | 1998 |
The physiological response of thrombopoietin (c-Mpl ligand) to thrombocytopenia in the rat.
Topics: Animals; Antineoplastic Agents, Alkylating; Blood Platelets; Busulfan; Male; Platelet Count; Rats; R | 1999 |
Short course of busulphan in essential thrombocythaemia: remodelling of an old strategy.
Topics: Adult; Aged; Busulfan; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Age | 2000 |
Remission induction in chronic granulocytic leukaemia using intermittent high-dose busulphan.
Topics: Busulfan; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Leukemia, Myeloid; | 1978 |
Some uses of the continuous flow blood separator in the myeloproliferative syndrome.
Topics: Adult; Busulfan; Female; Gangrene; Humans; Infant, Newborn; Leukapheresis; Leukemia, Myeloid; Male; | 1978 |
Prognostic signs in chronic myelocytic leukemia.
Topics: Blood Cell Count; Busulfan; Cholesterol; Chromosomes, Human, 21-22 and Y; Female; Humans; Leukemia, | 1979 |
The influence of drugs on disseminated intravascular coagulation (dic). III. Effects of busulfan-induced thrombocytopenia and inhibition of platelet function by acetylsalicylic acid.
Topics: Animals; Aspirin; Busulfan; Disseminated Intravascular Coagulation; Fibrinogen; Male; Platelet Aggre | 1979 |
Contribution of platelets to the cardiovascular effects of ADP in the rat.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Blood Pressure; Busulfan; Immune Sera; Infusions, P | 1978 |
The effect of leukocyte and platelet transfusion on the activation of intravascular coagulation by endotoxin in granulocytopenic and thrombocytopenic rabbits.
Topics: Agranulocytosis; Animals; Blood Platelets; Blood Transfusion; Busulfan; Disseminated Intravascular C | 1976 |
Fibrinogen response to turpentine and endotoxin in busulfan-treated rabbbits.
Topics: Agranulocytosis; Animals; Busulfan; Endotoxins; Fibrinogen; Male; Rabbits; Thrombocytopenia; Turpent | 1976 |
Induced fat embolism in rabbits: effects of defibrinogenation and thrombocytopenia.
Topics: Ancrod; Animals; Busulfan; Embolism, Fat; Fibrinogen; Lung; Male; Organ Size; Pulmonary Edema; Pulmo | 1976 |
Hydroxyurea in the management of the hematologic complications of chronic granulocytic leukemia.
Topics: Busulfan; Humans; Hydroxyurea; Leukemia, Myeloid; Leukocyte Count; Leukocytosis; Mitobronitol; Splen | 1975 |
[Differential diagnosis of atypical chronic myeloid leukaemia].
Topics: Aged; Alkaline Phosphatase; Busulfan; Diagnosis, Differential; Fetal Hemoglobin; Hepatomegaly; Human | 1976 |
The role of blood platelets in the precipitation of soluble fibrin by endotoxin.
Topics: Animals; Blood Coagulation; Blood Platelets; Busulfan; Chemical Precipitation; Depression, Chemical; | 1975 |
Cardiopulmonary dysfunctions caused by intravenous collagen-induced release of ADP and ATP from platelets.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Blood Platelets; Busulfan; Central Venous Pr | 1975 |
Activation of intravascular coagulation by endotoxin: the significance of granulocytes and platelets.
Topics: Animals; Blood Platelets; Busulfan; Endotoxins; Erythrocyte Aggregation; Female; Granulocytes; Leuko | 1976 |
Possible involvement of platelets in Plasmodium yoelii nigeriensis malaria infection in mice.
Topics: Animals; Bleeding Time; Blood Platelets; Busulfan; Hematocrit; Malaria; Male; Mice; Plasmodium yoeli | 1991 |
Bone marrow transplantation in sickle cell anaemia.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Bone Marrow Transplantation; Busulfan; Child; Child, Prescho | 1991 |
GM-CSF in busulfan overdosage.
Topics: Anemia; Bone Marrow Diseases; Busulfan; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hu | 1990 |
The role of platelets in mesangial localization: carbon uptake in thrombocytopenic rats.
Topics: Animals; Blood Platelets; Busulfan; Carbon; Glomerular Mesangium; Leukocyte Count; Liver; Male; Phag | 1985 |
Delayed toxic effect of busulfan on the marrow.
Topics: Adult; Bone Marrow Diseases; Busulfan; Female; Humans; Leukemia, Myeloid; Leukopenia; Male; Middle A | 1973 |
Splenectomy for thrombocytopenia in chronic granulocytic leukemia.
Topics: Adult; Blood Platelets; Busulfan; Child; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hum | 1972 |
Disseminated intravascular coagulation induced by liquoid in normal, thrombocytopenic and granulocytopenic rabbits. Light and electron microscope studies.
Topics: Agranulocytosis; Animals; Blood Cell Count; Blood Platelets; Blood Proteins; Busulfan; Capillaries; | 1972 |
[Acute hemopericardium due to acute thrombocytopenia developing during Busulphan treatment of polycythemia vera].
Topics: Acute Disease; Adult; Anemia, Aplastic; Busulfan; Cardiac Tamponade; Humans; Male; Pericardial Effus | 1973 |
Influence of platelet count on haemostatic plug formation and plug stability. An experimental study in rabbits with graded thrombocytopenia.
Topics: Anemia; Animals; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Busulfan; Ethylenes; Fe | 1973 |
[Treatment of chronic myeloid leukemia and lymphoreticular sarcoma with piposulfan].
Topics: Adult; Aged; Anemia, Aplastic; Antineoplastic Agents; Busulfan; Female; Humans; Leukemia, Myeloid; L | 1970 |
[Results of long-term treatment of polycythemia vera with busulfan (Myleran) or dibromomannitol (Myelobromol): analysis of 4 clinical cases observed and treated during more than 7 years].
Topics: Aged; Antineoplastic Agents; Busulfan; Female; Follow-Up Studies; Humans; Leukopenia; Long-Term Care | 1969 |
Platelet defects in post-splenectomy thrombocythaemia.
Topics: Adenosine Diphosphate; Adult; Blood Coagulation Factors; Blood Platelet Disorders; Busulfan; Collage | 1971 |
Intravascular clotting induced by antigen-antibody reactions: protection by extreme thrombocytopenia.
Topics: Animals; Antigen-Antibody Reactions; Blood Platelets; Busulfan; Capillaries; Disseminated Intravascu | 1971 |
[Treatment of polycythemia vera].
Topics: Anemia, Aplastic; Busulfan; Humans; Leukopenia; Male; Middle Aged; Polycythemia Vera; Thrombocytopen | 1971 |
[Analysis of results of treatment with myleran in 100 cases of chronic myelogenous leukemia].
Topics: Adolescent; Adult; Busulfan; Female; Humans; Leukemia, Myeloid; Leukopenia; Male; Middle Aged; Throm | 1968 |
[Chronic myelogenous leukemia. Results of therapy with busulfan].
Topics: Adult; Age Factors; Aged; Ambulatory Care; Blood Transfusion; Busulfan; Chronic Disease; Female; Fol | 1969 |
[Aplastic syndrome in myleran overdose].
Topics: Adrenal Cortex Hormones; Anemia, Aplastic; Anti-Bacterial Agents; Anticoagulants; Blood Transfusion; | 1971 |
Myelofibrosis in chronic granulocytic leukemia.
Topics: Adolescent; Adult; Alkaline Phosphatase; Anemia; Bone Marrow Examination; Busulfan; Chromosome Aberr | 1971 |
Testing for Ph 1 chromosome on mailed specimens of peripheral blood.
Topics: Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Antimetabolites; Blood Specimen Collection; Bo | 1971 |
"Secondary" thrombocythemia associated with chronic myelogenous leukemia and complicated by dental hemorrhage.
Topics: Adult; Busulfan; Humans; Leukemia, Myeloid; Male; Oral Hemorrhage; Pressure; Sutures; Thrombocytopen | 1968 |
The effect of vincristine on the platelet count in rats.
Topics: Animals; Blood Cell Count; Blood Platelets; Bone Marrow; Bone Marrow Cells; Busulfan; Megakaryocytes | 1970 |
Do platelets enhance thromboplastin-induced intravascular clotting?
Topics: Animals; Blood Cell Count; Blood Coagulation; Blood Platelets; Busulfan; Factor IX; Factor V; Factor | 1970 |
Effects of a cytostatic agent and of a fibrinstabilizing factor on atherosclerosis in the rabbit.
Topics: Animals; Aorta; Arteriosclerosis; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Blood | 1970 |
The management of platelet disorders.
Topics: Blood Platelets; Blood Transfusion; Busulfan; Glucocorticoids; Humans; Immunosuppressive Agents; Pho | 1968 |
Procarbazine (Natulan) and busulfan in the treatment of polycythemia vera.
Topics: Adult; Aged; Antineoplastic Agents; Busulfan; Female; Humans; Hydrazines; Leukopenia; Male; Middle A | 1968 |
Intravascular coagulation with generalized Shwartzman reaction induced by liquoid: lack of protection by extreme thrombocytopenia.
Topics: Animals; Anticoagulants; Autopsy; Blood Cell Count; Blood Coagulation Disorders; Blood Coagulation T | 1968 |
Experimental thrombocytopenia induced by Busulphan (Myleran) in rabbits: extremely low platelet levels and intact plasma clotting system.
Topics: Animals; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Busulfan; He | 1968 |
[Present treatment of the Vaquez's disease].
Topics: Aged; Anemia; Anticoagulants; Antineoplastic Agents; Blood Donors; Blood Volume; Bloodletting; Busul | 1969 |
[The role of the thrombocytes in the induction of intravascular coagulation].
Topics: Animals; Blood Coagulation Disorders; Blood Platelets; Busulfan; Fibrin; Fibrinogen; Hemolysis; Inje | 1969 |
Myeloproliferative disease complicated by megaloblastic anemia and hyperuricemia.
Topics: Anemia, Macrocytic; Blood; Blood Coagulation Disorders; Busulfan; Enzyme Therapy; Epistaxis; Female; | 1965 |
Basophilic leukemia.
Topics: Alkaline Phosphatase; Bone Marrow; Busulfan; Female; Humans; Leukemia; Male; Mast Cells; Middle Aged | 1966 |